AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AADI

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/03/05	08 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/05	08 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/05	08 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/05	07 : 58	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/05	06 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/05	06 : 05	PR Newswire (US)	Aadi Bioscience Announces Closing of $100 Million PIPE Financing	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/04	10 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/04	10 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/04	10 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/04	10 : 34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/04	10 : 31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/03/03	22 : 00	PR Newswire (US)	Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/24	22 : 00	PR Newswire (US)	Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/20	07 : 08	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/19	06 : 58	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/19	06 : 22	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/18	22 : 00	PR Newswire (US)	Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/15	02 : 11	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/06	06 : 49	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/06	06 : 05	PR Newswire (US)	Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025	NASDAQ:AADI	Aadi Bioscience Inc
2025/02/01	07 : 09	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:AADI	Aadi Bioscience Inc
2025/01/30	09 : 01	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:AADI	Aadi Bioscience Inc
2025/01/25	04 : 34	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:AADI	Aadi Bioscience Inc
2025/01/22	06 : 54	Edgar (US Regulatory)	Form PREM14A - Preliminary proxy statements relating to merger or acquisition	NASDAQ:AADI	Aadi Bioscience Inc
2024/12/31	07 : 04	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AADI	Aadi Bioscience Inc
2024/12/24	07 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/12/24	07 : 34	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/12/24	07 : 26	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:AADI	Aadi Bioscience Inc
2024/12/24	05 : 51	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:AADI	Aadi Bioscience Inc
2024/12/20	20 : 08	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AADI	Aadi Bioscience Inc